Menopause and Hormone Replacement PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Menopause and Hormone Replacement PDF full book. Access full book title Menopause and Hormone Replacement by Hilary O. D. Critchley. Download full books in PDF and EPUB format.
Author: Hilary O. D. Critchley
Publisher:
ISBN: 9781904752110
Category : Menopause
Languages : en
Pages : 364
Get Book
Book Description
Author: Hilary O. D. Critchley
Publisher:
ISBN: 9781904752110
Category : Menopause
Languages : en
Pages : 364
Get Book
Book Description
Author:
Publisher:
ISBN:
Category : Hormone therapy
Languages : en
Pages : 12
Get Book
Book Description
Author:
Publisher:
ISBN:
Category : Health & Fitness
Languages : en
Pages : 136
Get Book
Book Description
An information guide to information on the subject of menopause.
Author: Sics Editore
Publisher: SICS Editore
ISBN: 8869305503
Category : Medical
Languages : en
Pages : 62
Get Book
Book Description
Tell the patient the basic facts, the advantages and disadvantages of the hormone therapy as well as the health benefits and risks of long-term use. The final decision about starting the treatment is made by the patient. Discuss the alternatives of hormone therapy. The younger the patient is at the onset of menopause, the more readily the treatment should be started. Add progestogen to the oestrogen therapy for women with an intact uterus. The primary indication for postmenopausal hormone replacement therapy (HRT) is the treatment of menopausal symptoms.
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309157331
Category : Social Science
Languages : en
Pages : 428
Get Book
Book Description
In 1950 men and women in the United States had a combined life expectancy of 68.9 years, the 12th highest life expectancy at birth in the world. Today, life expectancy is up to 79.2 years, yet the country is now 28th on the list, behind the United Kingdom, Korea, Canada, and France, among others. The United States does have higher rates of infant mortality and violent deaths than in other developed countries, but these factors do not fully account for the country's relatively poor ranking in life expectancy. International Differences in Mortality at Older Ages: Dimensions and Sources examines patterns in international differences in life expectancy above age 50 and assesses the evidence and arguments that have been advanced to explain the poor position of the United States relative to other countries. The papers in this deeply researched volume identify gaps in measurement, data, theory, and research design and pinpoint areas for future high-priority research in this area. In addition to examining the differences in mortality around the world, the papers in International Differences in Mortality at Older Ages look at health factors and life-style choices commonly believed to contribute to the observed international differences in life expectancy. They also identify strategic opportunities for health-related interventions. This book offers a wide variety of disciplinary and scholarly perspectives to the study of mortality, and it offers in-depth analyses that can serve health professionals, policy makers, statisticians, and researchers.
Author: Rogerio A. Lobo
Publisher: Academic Press
ISBN:
Category : Medical
Languages : en
Pages : 926
Get Book
Book Description
For anyone who treats postmenopausal women, this latest edition of Rogerio Lobo's classic work combines the best from two well-known references: Menopause, and the second edition of Treatment of the Postmenopausal Woman. By adding significant discussions of the basic science behind menopause, it is possible to objectively assess the clinical value and limitations of current approaches to treatment and provide a basis and rationale for strategies that will result in better individualized and specialized care. Not only does the third edition discuss diagnosis and treatment of menopause but it covers biological, anatomical, physiological, pathobiological, and pharmacological aspects as well bringing together, in one source, all of the information needed to understand and treat postmenopausal conditions. Over 50% new material representing the vast amount of information available since the Women's Health Initiative (WHI) clinical trials were completed making this the most up-to-date reference on postmenopausal women Includes several new sections on comparisons between clinical trials and observational data, urology, and pelvic support Each section is preceded by a preface to put the area into context with many chapters having suggested treatment regimens
Author: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
Publisher: World Health Organization
ISBN:
Category : Medical
Languages : en
Pages : 692
Get Book
Book Description
Evaluates evidence for an increased risk of cancer in women using combined oral contraceptives, progestogen-only hormonal contraceptives, post-menopausal estrogen therapy, and post-menopausal estrogen-progestogen therapy. Although the carcinogenicity of these preparations has been extensively investigated, the book stresses the many complex methodological issues that must be considered when interpreting findings and weighing results. Evidence of an association between use of these preparations and positive effects on health, including a reduced risk of some cancers, is also critically assessed. The first and most extensive monograph evaluates evidence of an association between the use of combined oral contraceptives and cancer at nine sites. Concerning breast cancer, the evaluation concludes that, even if the association is causal, the excess risk for breast cancer associated with patterns of use that are typical today is very small. Studies of predominantly high-dose preparations found an increased risk of hepatocellular carcinoma in the absence of hepatitis viruses. Citing these findings, the evaluation concludes that there is sufficient evidence in humans for the carcinogenicity of combined oral contraceptives. The evaluation also found sufficient evidence for the carcinogenicity of some, but not all, combined preparations in animals. Combined oral contraceptives were classified as carcinogenic to humans. The evaluation also cites conclusive evidence that these agents have a protective effect against cancers of the ovary and endometrium. Progestogen-only contraceptives are evaluated in the second monograph, which considers the association with cancer at six sites. The evaluation found no evidence of an increased risk for breast cancer. Although the evaluation found sufficient evidence in animals for the carcinogenicity of medroxyprogesterone acetate, evidence for the carcinogenicity of progestogen-only contraceptives in humans was judged inadequate. Progestogen-only contraceptives were classified as possibly carcinogenic to humans. The third monograph, on post-menopausal estrogen therapy, considers evidence of an association with cancer at eight sites. Findings from a large number of epidemiological studies indicate a small increase in the risk of breast cancer in women who have used these preparations for five years or more. Studies consistently show an association between use of post-menopausal estrogen therapy and an increased risk for endometrial cancer. Data on the association with other cancers were either inconclusive or suggested no effect on risk. The evaluation concludes that post-menopausal estrogen therapy is carcinogenic to humans. The final monograph evaluates the association between the use of post-menopausal estrogen-progestogen therapy and cancer at four sites. The evaluation of limited data on breast cancer found an increased relative risk observed with long-term use. Data were judged insufficient to assess the effects of past use and of different progestogen compounds, doses, and treatment schedules. For endometrial cancer, the evaluation found an increase in risk relative to non-users when the progestogen was added to the cycle for 10 days or fewer. Post-menopausal estrogen-progestogen therapy was classified as possibly carcinogenic to humans. Concerning post-menopausal therapy in general, the book notes that evidence of carcinogenic risks must be placed in perspective of potential benefits. The prevention of osteoporotic fractures is cited as the best-established benefit. Evidence also suggests that estrogen prevents heart disease and may prevent memory loss and dementia.
Author: R. Don Gambrell
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 156
Get Book
Book Description
This publication written by an acknowledged expert, has been developed in the center index format. The purpose of the center index system is to enable readers to immediately locate all the information contained in the book. Tabs are provided with each center index so there is a direct connection between the center index & text. This enables the reader to proceed to any area of the text without having to read information not relevant to the situation. The additional information that should be included for each text will be the title, authors name, date of publication, & ISBN. Our company address is Essential Medical Information Systems, Inc. P.O. Box 1607, Durant, OK 74702-1607 or call 1-800-225-0694.
Author: Lorraine Dennerstein
Publisher: American Psychiatric Publishing
ISBN:
Category : Estrogen
Languages : en
Pages : 156
Get Book
Book Description
Every woman, as she gets older, must face the onset of menopause-either naturally occurring or brought on surgically. As we learn more about menopause and the effects of hormone replacement therapy (HRT), a number of questions arise. The most hotly debated of them all: should women receive HRT? This book grew out of the need for a balanced examination of all the relevant issues-not for medical practitioners but for women of all ages-and is written in the context of how women experience the transition of menopause. Drawing on a number of population studies and their own research, contributors from different fields take on subjects ranging from HRT as a social issue and the psychosocial aspects of menopause to the role of diet and exercise in midlife health and what natural therapies may have to offer women. Other chapters thoroughly discuss the pros and cons of HRT and explain what hormones are and what they do. Readers will find the latest facts and medical opinions on how HRT can affect the likelihood of developing osteoporosis and bone fractures, breast and gynecological cancers, cardiovascular diseases, and menopausal symptoms such as hot flashes, night sweats, urinary problems, and vaginal thinning. For the millions of women who fall somewhere in the middle of the spectrum of menopausal symptoms-and those at either end of the continuum-this easy-to-understand guide blends thought-provoking opinion with facts into one clear, concise source.
Author: Katherine Sherif
Publisher: Springer Science & Business Media
ISBN: 1461462681
Category : Medical
Languages : en
Pages : 132
Get Book
Book Description
Hormone Therapy: A Clinical Handbook provides a comprehensive overview on hormone replacement therapy, with a range of key features that differentiate it from other titles on the topic. This concise, handy title presents an interdisciplinary approach to the subject, acknowledging that sex hormones affect more than reproductive organs and hot flushes for a deeper understanding of how hormones function. The authors provide a breadth and depth of practical prescribing experience, including many helpful tables and algorithms as well as directions for prescribing hormone therapy in the most effective and safest ways possible. Targeted and easy to read, Hormone Therapy: A Clinical Handbook offers all clinicians the state-of-the-art information they need to prescribe hormone therapy and hormone replacement therapy.
